9 unknown. 9 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Unknown 9 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Malabsorption Syndromes: new trials by email Literature Review of Malabsorption Syndromes trials Research Report on Malabsorption Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Probiotic Blend for Celiac Disease Probiotic blend, Placebo - Celiac Disease | Phase 2 | Unknown | Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | 118 | 2022-11-17 | 2022-12-12 |
| Proof of Concept Study in Patients With Short Bowel Syndrome NM-002 - Short Bowel Syndrome | Phase 1 / Phase 2 | Unknown | 9 Meters Biopharma, Inc. | 12 | 2020-06-23 | 2020-11-20 |
| A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) Nexvax2, Placebo - Celiac Disease, Celiac | Phase 2 | Unknown | ImmusanT, Inc. | 146 | 2018-08-06 | 2019-03-19 |
| Efficacy of Probiotic ES1 for the Treatment of Non-Celiac Gluten Sensitivity Probiotic ES1, Placebo - Non-Celiac Gluten Sensitivity | Phase 2 | Unknown | Exzell Pharma Inc. | 60 | 2016-04-01 | 2016-10-07 |
| Wheat Flour Treatment With Microbial Transglutaminase and Lysine Ethyl Ester: New Frontiers in Celiac Disease Treatment. rusks made of wheat flour enzymatically treated, rusks made of wheat flour not enzimatically modified, Gluten-free diet - Celiac Disease | Phase 2 | Unknown | University of Roma La Sapienza | 20 | 2015-06-01 | 2015-06-15 |
| Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients ALV003, placebo - Celiac Disease | Phase 2 | Unknown | Alvine Pharmaceuticals Inc. | 500 | 2013-08-01 | 2014-12-17 |
| Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine Amlodipine, amlodipine-FA tablet, low dose group, amlodipine-FA tablet ,high dose group - Essential Hypertension | Phase 2 / Phase 3 | Unknown | Shenzhen Ausa Pharmed Co.,Ltd | 756 | 2013-01-01 | 2013-05-08 |
| Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease Omegaven Therapy - Short Bowel Syndrome, Cholestasis | Phase 2 | Unknown | Amarnath, Rathna, M.D. | 20 | 2009-03-01 | 2012-12-03 |
| Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants? Intralipid 20%, SMOFlipid 20% - Short Bowel Syndrome, Intestinal Failure | Phase 2 | Unknown | The Hospital for Sick Children | 24 | 2009-01-01 | 2011-11-03 |
Celiac Disease (5) · Short Bowel Syndrome (3) · Autoimmune Diseases (1) · Cholestasis (1) · Digestive System Diseases (1) · Essential Hypertension (1) · Gastrointestinal Diseases (1) · Hyperhomocysteinemia (1) · Hyperphagia (1) · Hypertension (1) · Intestinal Diseases (1) · Intestinal Failure (1) · Liver Failure (1)
Digestive System Diseases (7) · Gastrointestinal Diseases (7) · Intestinal Diseases (7) · Metabolic Diseases (6) · Nutritional and Metabolic Diseases (6) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Postoperative Complications (3) · Amino Acid Metabolism, Inborn Errors (1) · Avitaminosis (1) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
ALV003 (1) · Amlodipine (1) · Contraceptives, Oral (1) · Diet, Gluten-Free (1) · Nexvax2 (1) · Population Groups (1)
9 Meters Biopharma, Inc. (1) · Alvine Pharmaceuticals Inc. (1) · Amarnath, Rathna, M.D. (1) · Exzell Pharma Inc. (1) · ImmusanT, Inc. (1) · Shenzhen Ausa Pharmed Co.,Ltd (1) · The Hospital for Sick Children (1) · Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude (1) · University of Roma La Sapienza (1)
United States (4) · Canada (3) · Australia (1) · Brazil (1) · China (1) · Finland (1) · Ireland (1) · Italy (1) · New Zealand (1) · Norway (1) · United Kingdom (1)
Daniel Adelman, MD (1) · Dr. Pardeep Nijhawan, MD (1) · Paul Wales (1) · Robert Anderson, PhD, FRACP (1) · Terra R Varner, PharmD (1) · Yong Huo, MD (1)
PMID 26838529, PMID 27864127, PMID 28343108, PMID 28755266, PMID 33239013, PMID 36898393, PMID 42861767